Edition:
United Kingdom

Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

646.95INR
16 Nov 2018
Change (% chg)

Rs-17.90 (-2.69%)
Prev Close
Rs664.85
Open
Rs671.20
Day's High
Rs674.00
Day's Low
Rs645.40
Volume
688,643
Avg. Vol
926,573
52-wk High
Rs711.90
52-wk Low
Rs493.50

Chart for

About

Glenmark Pharmaceuticals Limited is a global pharmaceutical company. The Company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW). It has approximately seven molecules, over two NCEs and... (more)

Overall

Beta: 0.27
Market Cap(Mil.): Rs172,813.91
Shares Outstanding(Mil.): 282.17
Dividend: 2.00
Yield (%): 0.33

Financials

  GLEN.NS Industry Sector
P/E (TTM): 14.21 31.23 33.59
EPS (TTM): 43.09 -- --
ROI: -- 15.57 15.05
ROE: -- 16.94 16.62

BRIEF-Glenmark Pharmaceuticals Submitts NDA To U.S. FDA For Ryaltris

* GLENMARK PHARMACEUTICALS - SUBMITTED NDA TO U.S. FDA FOR LEADING RESPIRATORY PIPELINE CANDIDATE RYALTRIS Source text for Eikon: Further company coverage:

21 May 2018

Earnings vs. Estimates